Heart disease screening with AI-enabled ECG and focused ultrasound

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial will use 6-lead AI-ECG and AI FoCUS ultrasound to screen for cardiac disease in adolescents, young adults, community-dwelling adults, and pregnant women at Mayo Clinic locations in Rochester, MN. It aims to determine feasibility, diagnostic yield, accuracy, and actionable thresholds with immediate feedback. Participants must meet age and consent criteria and exclude those with pacemakers or poor-quality ECGs. The study is interventional but does not specify a traditional randomization or control group. Enrollment spans multiple demographic subgroups to assess broad applicability in real-world settings.

Why it matters

Who can join: the full rules

Adolescents and young adults:

Inclusion Criteria:

* Enrollment in a high-school, college or a resident in MN during the study period
* Age 18-29 years
* Informed consent (and assent for minors)

Exclusion Criteria:

* Presence of a pacemaker or defibrillator
* Inability to obtain a quality ECG tracing

Community dwelling adults:

Inclusion Criteria:

• Adult patients (\>30 years of age, with pre-specified subgroups 30-64 and 65+))

Exclusion Criteria:

• Inability to provide informed consent to participate in the study

Pregnant women:

Inclusion Criteria:

* Adult female aged 18 to 49 years
* Pregnant at the time of enrollment
* Receiving obstetric care at identified study site(s)
* Willing and able to provide informed consent

Exclusion Criteria:

• Inability to provide consent

Where it's running

• Mayo Clinic in Rochester
  Rochester, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Paul Friedman, MD — Mayo Clinic
• Study coordinator: Amanda Priebe
• Email: Priebe.Amanda@mayo.edu
• Phone: 507-422-6932

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Cardiac Function and Anesthesia Depth During Heart Surgery

  This study tests whether deeper or lighter anesthesia affects heart function during elective heart surgery with bypass in adults.

  Recruiting AHEPA University Hospital · Thessaloniki · NCT07770269

• DigitHeart Echo: predicting heart ultrasound findings from a smartphone photo of your ECG

  This test checks whether a smartphone app can predict echocardiogram findings from a photo of a 12‑lead ECG in adults scheduled for echocardiography.

  Recruiting The University of Hong Kong · Hong Kong · NCT07558109

• Using blood flow measurements during bypass surgery to predict graft openness and recovery

  This trial will test whether using a device that measures blood flow during coronary bypass surgery helps surgeons ensure grafts stay open and improves recovery for adults having their first non-emergency multivessel CABG.

  Recruiting Weill Medical College of Cornell University · New York, New York · NCT07485738

• Tiny ultrasound bubbles as an alternative to catheters for measuring pressures inside the heart

  This will test whether injecting tiny ultrasound bubbles can estimate heart filling pressures in people who are having a cardiac catheterisation.

  Recruiting King's College London · London · NCT07416279

• Using the Supira percutaneous ventricular assist device during and after high-risk PCI

  This study will try the Supira percutaneous ventricular assist device to give extra heart support during and after high-risk PCI for patients with heart failure and reduced ejection fraction.

  Recruiting at 2 sites Supira Medical · Tbilisi, K'alak'i T'bilisi and 1 other locations · NCT07407816

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.